| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s?
|
De Waele, Jan J.
|
|
|
47 |
1 |
p. 104-106
|
article
|
| 2 |
Antiseptic mouthwash, the nitrate–nitrite–nitric oxide pathway, and hospital mortality: a hypothesis generating review
|
Blot, Stijn
|
|
|
47 |
1 |
p. 28-38
|
article
|
| 3 |
Biomarkers in the ICU: less is more? No
|
Torres, Antoni
|
|
|
47 |
1 |
p. 97-100
|
article
|
| 4 |
Biomarkers in the ICU: less is more? Not sure
|
Póvoa, Pedro
|
|
|
47 |
1 |
p. 101-103
|
article
|
| 5 |
Biomarkers in the ICU: less is more? Yes
|
Huang, David T.
|
|
|
47 |
1 |
p. 94-96
|
article
|
| 6 |
Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study
|
,
|
|
|
47 |
1 |
p. 60-73
|
article
|
| 7 |
Clinical validation of precision medicine protocols: the last mile is the longest
|
Casaer, Michael P.
|
|
|
47 |
1 |
p. 80-82
|
article
|
| 8 |
Comparison of mechanical power estimations in mechanically ventilated patients with ARDS: a secondary data analysis from the EPVent study
|
Schaefer, Maximilian S.
|
|
|
47 |
1 |
p. 130-132
|
article
|
| 9 |
Correction to: Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS
|
Ferrando, Carlos
|
|
|
47 |
1 |
p. 144-146
|
article
|
| 10 |
COVID-19 and ARDS: the baby lung size matters
|
Gattinoni, Luciano
|
|
|
47 |
1 |
p. 133-134
|
article
|
| 11 |
COVID-19: what the clinician should know about post-mortem findings
|
Jonigk, Danny
|
|
|
47 |
1 |
p. 86-89
|
article
|
| 12 |
Differences in clinical deterioration among three sub-phenotypes of COVID-19 patients at the time of first positive test: results from a clustering analysis
|
,
|
|
|
47 |
1 |
p. 113-115
|
article
|
| 13 |
Do ICU-acquired neuromuscular complications impact long-term mortality in general ICU patients?
|
Okazaki, Yuji
|
|
|
47 |
1 |
p. 135-136
|
article
|
| 14 |
Efficacy and safety of tranexamic acid in acute traumatic brain injury: a systematic review and meta-analysis of randomized-controlled trials
|
Lawati, Kumait Al
|
|
|
47 |
1 |
p. 14-27
|
article
|
| 15 |
Impact of late administration of corticosteroids in COVID-19 ARDS
|
Mongardon, Nicolas
|
|
|
47 |
1 |
p. 110-112
|
article
|
| 16 |
Is severe COVID-19 pneumonia a typical or atypical form of ARDS? And does it matter?
|
Goligher, Ewan C.
|
|
|
47 |
1 |
p. 83-85
|
article
|
| 17 |
Moral distress in the intensive care unit during the pandemic: the burden of dying alone
|
Kanaris, Constantinos
|
|
|
47 |
1 |
p. 141-143
|
article
|
| 18 |
Neuroanatomical substrates of generalized brain dysfunction in COVID-19
|
Newcombe, Virginia F. J.
|
|
|
47 |
1 |
p. 116-118
|
article
|
| 19 |
Neurofilament light as an outcome predictor after cardiac arrest: a post hoc analysis of the COMACARE trial
|
Wihersaari, Lauri
|
|
|
47 |
1 |
p. 39-48
|
article
|
| 20 |
Neurofilament to predict post-anoxic neurological outcome: are we ready for the prime time?
|
Taccone, Fabio S.
|
|
|
47 |
1 |
p. 77-79
|
article
|
| 21 |
Organizational aspects of care associated with mortality in critically ill COVID-19 patients
|
Rimmelé, Thomas
|
|
|
47 |
1 |
p. 119-121
|
article
|
| 22 |
Paediatric Inflammatory Multisystem Syndrome Temporally-Associated with SARS-CoV-2 Infection: An Overview
|
Carter, Michael J.
|
|
|
47 |
1 |
p. 90-93
|
article
|
| 23 |
Prediction model for intracranial hypertension demonstrates robust performance during external validation on the CENTER-TBI dataset
|
Carra, Giorgia
|
|
|
47 |
1 |
p. 124-126
|
article
|
| 24 |
Propofol-infusion syndrome in traumatic brain injury: consider the ECMO option
|
Dauwe, Dieter Frans
|
|
|
47 |
1 |
p. 127-129
|
article
|
| 25 |
Pseudo B-line in pneumothorax: first look at the patient. Author’s reply
|
Wong, Adrian
|
|
|
47 |
1 |
p. 139-140
|
article
|
| 26 |
Temporal trends of outcomes of neutropenic patients with ARDS enrolled in therapeutic clinical trials
|
Price, David R.
|
|
|
47 |
1 |
p. 122-123
|
article
|
| 27 |
The PRICES statement: an ESICM expert consensus on methodology for conducting and reporting critical care echocardiography research studies
|
Sanfilippo, Filippo
|
|
|
47 |
1 |
p. 1-13
|
article
|
| 28 |
Tranexamic acid in traumatic brain injury: systematic review and meta-analysis trumps a large clinical trial?
|
Maas, Andrew I. R.
|
|
|
47 |
1 |
p. 74-76
|
article
|
| 29 |
Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial
|
Baksaas-Aasen, K.
|
|
|
47 |
1 |
p. 49-59
|
article
|
| 30 |
Weakness in the ICU: the right weight on the right scale
|
Van Aerde, Nathalie
|
|
|
47 |
1 |
p. 137-138
|
article
|
| 31 |
What’s new in ECMO for COVID-19?
|
MacLaren, Graeme
|
|
|
47 |
1 |
p. 107-109
|
article
|
Journal description